Pinpoint Therapeutics
About:
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Website: https://www.pinpointtherapeutics.com/
Twitter/X: PennPCI
Top Investors: Kairos Ventures
Description:
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy, a key cell survival and treatment resistance pathway in cancer. Pinpoint inhibitors target a recently discovered enzyme in the autophagy pathway called PPT1, which is highly expressed across most cancers. These inhibitors could be applied to a broad range of cancers alone or in combination to overcome therapy resistance.
$1M
$1M to $10M
Philadelphia, Pennsylvania, United States
2018-01-01
pciinfo(AT)pci.upenn.edu
Jeffrey Winkler, Ravi Amaravadi
51-100
2019-12-30
Private
© 2025 bioDAO.ai